1) 8-iso-prostaglandin F(2alpha)
8-异前列腺素F_2
2) 8-iso-prostaglandin F2ɑ
8-异-前列腺素F2ɑ
3) 8-iso-PGF2α
8-异前列腺素F2α
1.
The 8-iso-prostaglandin F2α(8-iso-PGF2α) levels in the renal tissue were determined by enzyme-linked immunosorbent assay(ELISA) and the superoxide dismutase(SOD) activity was detected by chemilumi-nescent analysis.
采用抗原竞争ELISA法检测大鼠肾组织8-异前列腺素F2α(8-iso-PGF2α)水平,黄嘌呤氧化酶化学发光测定法检测其超氧化物歧化酶(SOD)活性。
2.
Objective: To detect the changes of 8-iso-prostaglandin F2α (8-ISO-PGF2α) in serum and the hippocampus and to observe the intervention effect of apigenin in immature rats exposing to intermittent hypoxic.
目的:观察间歇低氧幼鼠血清及海马8-异前列腺素F2α(8-ISO-PGF2α)的变化及芹菜素的干预效果。
3.
Objective:To investigat the plasma 8-iso-prostaglandin F2α(8-iso-PGF2α)and the serum C-reactive protein(CRP)levels in patients with chronic obstructive pulmonary disease(COPD),and also explore the pathogenesis of COPD.
目的:检测慢性阻塞性肺疾病(COPD)患者血浆8-异前列腺素F2α(8-iso-PGF2α)及血清C反应蛋白(CRP)水平的变化,探讨COPD的发病机制。
4) 8-Iso-prostaglandin F2α
8-异前列腺素F2α
1.
8-iso-prostaglandin F2α and Type 2 Diabetes Mellitus;
8-异前列腺素F2α与2型糖尿病
2.
Objective To evaluate the therapeutic effect of N-acetylcysteine(NAC) against myocardial ischemia-reperfusion injury during cardiopulmonary bypass(CPB) in infants with congenital heart disease(CHD),by exploring the chang of levels of plasma 8-iso-prostaglandin F2α(8-iso-PGF2α),in order to provide a new method for prevention and cure of the lipid peroxidation damage at CPB stage.
目的探讨先天性心脏病(CHD)患儿体外循环期(CPB)血浆8-异前列腺素F2α(8-iso-PGF2α)水平变化及其意义,并观察N-乙酰半胱氨酸(NAC)的干预效果,以期为CPB脂质过氧化损伤的防治提供新途径。
5) 8-iso-Prostaglandin F_(2a)
8-异前列腺素F2a
1.
Objective To explore the changes of blood 8-iso-Prostaglandin F_(2a)(8-iso-PGF_(2a))content in different time after building-model and study its significance,and study the intervention effect of N-acetylcysteine(NAC) on it.
目的探讨建立缺氧缺血性脑病(HIE)大鼠模型后不同时间段血8-异前列腺素F2a(8-iso-PGF2a)变化的意义,以及新型抗氧化剂N-乙酰半胱氨酸(NAC)对其干预效果。
6) 8-isoprostane
8-异前列腺素
1.
Changes and significances of 8-isoprostane in exhaled breath condensate in obstructive sleep apnea hypopnea syndrome
阻塞性睡眠呼吸暂停低通气综合征患者呼出气冷凝液中8-异前列腺素的检测及其临床意义
2.
primary part The Investigation of Serum 8-Isoprostane, GSH-Px inPatients with Obstructive Sleep Apnea/hypopnea Syndrome Objective To investigate the expression of Serum 8-isoprostane, glutathioneperoxidase(GSH-Px) in patients with obstructive sleep apnea/hypopnea syndrome(OSAHS), and explore changes of oxidative stress in patients of OSAHS in vivo.
第一部分阻塞性睡眠呼吸暂停低通气综合征患者血清8-isoprostane、GSH-Px的研究 目的研究阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者血清8-异前列腺素(8-isoprostane)及谷胱甘肽过氧化物酶(glutathione peroxidase，GSH-Px)的表达，探讨OSAHS患者体内氧化应激的改变。
3.
Objective To invesitgate the relationship between 8-isoprostane(8-iso-PG) level in exhaled breath condensates(EBCs) and severity of asthma and explore the role of 8-iso-PG in asthma evaluation and monitoring.
目的探讨哮喘患者呼出气冷凝液(EBC)中8-异前列腺素(8-iso-PG)水平与病情严重程度的关系,阐明EBC中8-iso-PG监测对评估哮喘气道氧化应激的价值。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条